ILO WEEK 7 & 8 Flashcards

Renal

1
Q

Give an account of the role of the kidneys in controlling the volume of extracellular fluid, metabolic waste removal and electrolyte homeostasis

A

The role of the kidney is to:

  • Remove metabolic waste from the extracellular fluid (urea, acids)
  • Controlling the volume of extracellular fluid ( close link to blood pressure)
  • Maintaining optimal concentration of vital solutes in the extracellular fluid (Na, K, Ca, Mg, Cl, Phos)
  • A few other functions have evolved as a result of kidneys unique physiology

Controls the volume by ADH and aqua poring; rest of the water follows sodium!

Metabolic waste; things reabsorbed and actively excreted from the body;

Loop of Henle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the composition of the nephron and explain the function of each component

A
  1. Glomerulus -> ultrafiltration; podocytes; leaky capillaries; pressure difference
  2. Proximal convoluted tubule -> active reabsorption; most occurs here-> all glucose and amino acids; lots of electrolytes and water
  3. Loop of Henle -> concentration; creating environment for water reabsorption ( descending water only; ascending electrolytes only) Sodium potassium chloride channels
  4. Distal convoluted tubule -> small reabsorption only; same as in proximal but just adjusting
  5. Collecting duct; collecting all; ADH water reabsorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Understand the other main functions of the kidneys, including activation of vitamin D, toxin metabolism and regulation of erythropoietin

A
  1. Vit D activation -> last stage of Vit D activation
  2. Regulation of erythropoein -> makes erythropoein -> making red blood cells
  3. Blood pressure regulation; macula densa; renin;angiotensin; aldosterone
  4. Toxin metabolism
    Some of toxin metabolism occurs in the kidney ( medicines; degoxin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Juxta-glomerular apparatus and blood flow

A

Juxta-glomerular apparatus:
Maintains GFR in face of increases or decreases in blood flow to the kidney

Macula densa - senses tubular flow; next to glomerulus

Increases tubular flow:
Sensed by macula densa
Macula densa produces adenosine -> afferent arteriolar constriction

Reduced tubular flow:
Sensed by macula densa; reduction in flow
Granular cells produce renin (green)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the common causes and classification of kidney disease

A

Defined by reduced eGFR and detection and qualification of urine protein +/- blood

Once defined a combination of history, examination and investigation is employed to identify aetiology

AKI (Acute Kidney Injury); CKD (Chronic Kidney Disease)

Common causes:

  • Ineffective blood supply (reduced effective plasma volume or narrowed renal arteries) mostly AKI
  • Glomerular diseases
  • Tubulo-interstitial diseases
  • Obstructive uropathy most AKI
  • For CKD -> Following acute kidney injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Oliguria

A

Warning od impending acute tubular necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List what is measured by semiquantitative urinalysis

A
  • Inspection
  • Dipstick testing
    Microscopy and quantification of detected protein
  • Depending on clinical situation- urine biochemistry (sodium, potassium, chloride, urea, osmolality)

Check:

  • Protein/Albumin
  • Haem
  • pH
  • Ketones
  • Glucose
  • Bilirubin
  • Leucocyte
  • Nitrites

Blood:

  • visible haematuria
  • non-visible (seen with a microscope)

Protein:
Measuring, need 24h sample

No normal values for electrolytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How proteinuria and Haematuria are quantified

A

Blood:

  • visible haematuria
  • non-visible (seen with a microscope)

Protein:
Measuring, need 24h sample
need a ratio with creatine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Identify patients with kidney injury by eGFR, serum creatine, dipstick urinanalysis and urine quantification

A
  • > eGFR <60 ml/min
  • > Rise in serum creatine within the eGFR> 60mL/min range
  • > Anion gap
  • > Blood and proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Management of Chronic Kidney Disease

A
  • > Dialysis
  • > Kidney transplant
  • > Increased cardiovascular risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the various methods available to image the kidneys and bladder and understand the risks associated with some of these methods

A
  • Plain X-ray
    (useful for radio-opaque stones
  • Ultrasound
    (no radiation; gains information about kidney size; shape; location; obstruction and renal blood flow)
  • CT
    ( Useful for trauma, stone, tumour, infection) (popular)
    Contrast enhanced imaging Blood supply and neighbouring structures; (IV iodinated contrast -> potentially methatoxic)

NEED to weight up benefits and potential nephrotoxicity; sometimes really needed

  • MRI
    Soft tissue evaluation; contrast can be toxic
  • Radioisotope scanning
    tracer needed
    information on: structure; perfusion; excretion; differential renal function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Understand how kidney stones/ crystals form, and the different types that exist

A

Crystals too much solute for the solution:
- calcium; Oxalate; Urate; Cysteine
Not enough solution: filtrate, urine
They form in urinary space

Classification:
By location:
- kidney/ nephrolithiasis
- ureter/ ureterolithiasis
- bladder/ cystolithiasis

By composition:

  • calcium- phosphate/ calcium-oxalate
  • urate/ cysteine/ struvite

Risk factors:
- male; 50% have a genetic component; positive family history
rise in obesity+ metabolic syndrome (DM/ HBP) have caused an increase in uric acid stones

Composition:
- Calcium containing (80%)
Calcium OXalate; Calcium Phosphate
Magnesioum ammonium Phosphate
Uric Acid; Cysteine; Mixed stones

HIGH SOLUTE STATES? LOW PREVENTER STATES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Understand the role of serum/ urine biochemistry and imaging in diagnosing kidney stones

A

pH Urine -> may be helpful in guiding diagnosis/ treatment:
Calcium stones pH >7.0
Struvite pH >7.0
Uric acid + cystine pH <6.0

High solute states: High calcium; High Oxalate/ Urate/ Cysteine/ Pro-calculi
CITRATE IS PROTECTIVE

Serum biochemistry tests: calcium, Phosphate, PTH, Urate, Bicarbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Discuss the common treatments for kidney stones

A

<2 cm expectant management or offer extracorporeal shock wave lithiotripsy
>2 cm or multiple stones -> expectant management ultrasonic litrotripsy
Large branched stones may require pul and eswl
Cysteine stones pul or open nephrolithotomy

Stones in ureter:

  • small have a good chance of paddage
  • allow time to pass
  • lower ureter - ureteroscopic stone removal
  • mid-upper ureter eswl
  • large stones -> >7mm eswl; ureteroscopic stone fragmentation
  • open surgery

IN ALL increase fluid! In some change the diet: (low oxalate; reduce protein/ sodium)

Citrate inhibitor of stone formation; can be increased by low Na diet

Struvite (Magnesium Ammonium Phosphate) -> Debulk where possible; Aggressive treatment of UTI (made by worms)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Functions of the kidney and consequence of failure in thees

A
  • Excretion small solutes -> consequence -> increased plasma concentration (e.g. urea, creatine)
  • Excretion of drugs -> drug toxicity
    (Done by filtration and tubular secretion)
  • Salt & water balance -> extracellular fluid overload or depletion
    Blood pressure control -> Hypertension
    ( Pressure natriuresis renin/angiotensin system, ADH, countercurrent mechanism, ANP/ BNP)
  • Electrolyte balance -> Hyperkalaemia, hypokalaemia
  • Acid base balance -> Metabolic acidosis
    ( Filtration then tubular cell membrane ‘pumps’)
  • Erythropoein -> Anaemia
  • Vit D activation -> Hypocalcaemia and secondary hyperparathytoidis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe how the nephron controls excretion of sodium and potassium

A

Potassium is mostly intracellular
Sodium and Chloride are in the interstitium

The kidney can only alter what it has filtered
Afferent arteriole Central nervous system
Efferent -> Angiotensin II constricting
+ ALL other mechanisms that control filtration

Then tubular reabsorption (active via channels) (passive down conc. gradient or osmotic gradient)
Tubular secretion -> In distal conv. tubule

Excretion = (Filtration - Reabsorption) + Secretion

17
Q

Explain how the kidney controls water reabsorption and secretion

A

Water follows sodium
Lots reabsorbed in the proximal conv. tubule;
In the loop of Henle; water leaved in the descending limb

The in distal and collecting duct; special system for further water reabsorption ADH; AQUAPORINS -> going down conc. gradient due to the loop of HENLE

18
Q

Describe how the countercurrent multiplier system concentrates filtrate in the loop of Henle

A

Descending -> only water permeable passive process
Ascending -> sodium, potassium, chloride permeable; Osmolality highest at the bottom; then electrolytes lost as it goes up -. Ends up being diluted at the top? all electrolytes are outside

19
Q

Understand how the countercurrent mechanism functions in the Vasa Recta

A

Vasa Recta is the vessel that appears in the juxtamedullary nephrons;
They flow in the opposite direction to the loop of Henle; but alongside it. It does not wash away the gradient as it flows in the opposite direction; It moves water into the ascending and electrolytes into the descending loop

20
Q

Understand the channels involved in electrolyte transport

A

Na+K+ ATPase and NaH antiporter (in PCT)

NKCC2 (Thick Ascending Loop of Henle)

NCC (DCT) (Na+ 2Cl-)

Aquaporins (Collecting Duct)

ENaCl (Cortical collecting duct)

IS THERE MORE?

21
Q

List the mail hormones involved in regulating renal function and understand how they act

A

Angiotensin II; Aldosterone; Renin -> Blood pressure; Contract on the afferent and efferent arterioles to go increase the flow (Maintain)

ADH and aquaporins -> open channels to allow passive passage of water out of the tubule

22
Q

Understand the mechanism involved in renal excretion of drugs

A

Drug elimination:

  1. Glomerular filtration; doses should be reduced if less filtration
  2. Tubular secretion
  3. Diffusion (non-ionic) - related to pH of urine/pKa of the drug ( important in aspirin)
  4. Protein-blinding ( in low serum albumin; more free and being filtered free fraction - rate of filtration
23
Q

Describe how impaired kidney function has an effect on drug metabolism and clearance

A

Problems:

  1. Toxicity
  2. Ineffective treatment

Relevant factors:

  1. Impaired drug absorption
  2. Impaired elimination
  3. Effect of renal dysfunction on hepatic drug metabolism
  4. Increased tissue sensitivity
  5. Protein binding
Impaired renal function:
Altered pharmacokinetics:
- decreased elimination
- decreased protein binding
- ALtered drug effect
Worsening of the existing condition
Enhancement of adverse effects
24
Q

Explain the dose adjustment options necessary in patients with compromised kidneys

A

Decreased elimination:
- Modify dose or monitor drug concentration

  • decreased dose -> decreased peak concentration
  • Increased dose interval -> decrease trough concentration (less exposure)
    Both -> more uniform serum concentration
    GOOD EXAMPLE: Gentamicin
25
Understand the mechanism and clinical presentation of nephrotoxicity
Mechanisms: - Pre-renal acute kidney injury (diuretics) - Glomerular damage - Nephrotic syndrome (immune complex) - Lupus syndrome - Tubular damage - Acute interstitial nephritis (immunological) - Acute Tubular necrosis (direct toxicity) - Anelgesic Nephropathy - Uretic obstruction (analgesics) Clinical presentation: - Acute kidney Injury ( interstitial nephritis/ ATN) - Chronic Renal Failure (nearly all, esp alengesics/ NSAIDs) - Nephrotic syndrome ( gold, penicilamine) - Lupus-like syndrome (hydralazine) - Nephrogenic DIaebtes Insipidus (lithium) - Fluid overload (NSAIDs) - Uraemia
26
Understand the use and misuse of diuretics
Use: - Loop diuretics (e.g. furosemide, bumetanide): Inhibit Na/K/2Cl co-transporter in TALH Increase K/Mg/Ca excretion Metabolic alkalosis Ototoxicity in high doses Used when oedema is a problem -> heart failure, need a shift of fluid also in kidney failure, some in hypertension, get rid of calcium - Thiazide diuretics (e.g. bendroflumethiazide, metolazone, chlorothiazide) Act on Na/C; cotransporter in DCT Less potent Used in hypertension; some in oedema but less Retain calcium; also nephrogenic diabetes Increased K/Mg excretion Can be used to reduce hypercalcuria (renal stones) Ineffective in kidney damage - Potassium spiring diuretics (spironolactone, amiloride): Spironolactone- mineralocorticoid receptor antagonist Useful for hyperaldosterone states (heart failure, cirrhosis) Amiloride- sodium channel blocker- blocks eNaC in collecting duct May be combined with loop to reduce K loss In hypokalaemic; K low; Used along side the others also in excess of aldosterone Get dangerous in kidney damage; concentration of K ``` Side effects: - Non-specific - GI upset - Hypersensitivity reactions - Thrombocytopenia Many others! Cardiac arrhythmia; Muscle weakness; Hyperkalaemia; Otottoxicity ```
27
Understand the mechanism by which chronic obstruction of bladder outflow can lead to back pressure, dysfunction and damage to the kidneys
Causes: - Benign Prostatic Hyperplasia - Bladder Stones - Kidney Stones - Bladder tumours - Causes back-flow up the ureters and buildup of urine; ureters become diluted and lose their peristaltic function -> urine can only flow down the ureters by the force of gravity - Dilation of renal pelvis and calyces known as HYDRONEPHROSIS -> untreated hydronephrosis can lead to progressive atrophy of the kidneys -> leads to kidney impairment
28
Outline the causes of chronic kidney disease and explain in brief the treatments given to the patient
Causes: - Can be multifactorial - Diabetes mellitus - Interstitial diseases - Hypertension - Glomerular disease Clinica features: - Increased urea and creatine - Hypertension, proteinuria and anaemia - Most patients tend to be asymptomatic until GFR falls below 30 mL/min/1.73m2 - Tiredness, breathless, anaemia, anorexia, weight loss, nausea, vomiting, then deep respiration in metabolic acidosis Effects: - Increased risk of Cardiovascular disease - Metabolic bone disease ( calcium and phosphate metabolism -> osteoporosis; Osteitis Fibrosa Cystica; Osteomalacia) - Impaired conversion of Vit D in the renal tubules; decreased Ca2+ absorption in the intestines - Increased risk of bleeding - Immune dysfunction MANAGEMENT: - ANTIHYPERTENSIVE TREATMENT -> slows the rate of decline - Reduction of proteinuria -> ACE inhibitors; Angiotensin receptor blockers - Dietary/ Lifestyle interventions -> reduce protein consumption, ensure sufficient caloric intake with limited intake of phosphate and potassium, stop smoking, control weight and do exercise - Treatment of Anaemia (EPO) - Maintaining fluid/ electrolyte balance -> give them sodium; if hyperkalaemia -> potassium-sparing diuretics should be stopped - Treatment of bone disease
29
Ideal characteristics of drugs in kidney impairment
Predominant hepatic/biliary elimination Less than 25% excreted unchanged No active metabolites Wide therapeutic margin Disposition unaffected by protein binding changes or by fluid balance changes Response unaffected by tissue sensitivity changes Not nephrotoxic
30
Hormonal control of Vasa Recta
Vasopressin